Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 6275 

    Article Cited by others


Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: A randomized controlled trial

Sharma Kapil, Pant Sanjay, Misra Sriprakash, Dwivedi Manisha, Misra Alok, Narang Sushil, Tewari Reshu, Bhadoria Ajeet S

Year : 2014| Volume: 20| Issue : 4 | Page no: 225-232

   This article has been cited by
1 Microbiome therapeutics for hepatic encephalopathy
Patricia P. Bloom, Elliot B. Tapper, Vincent B. Young, Anna S. Lok
Journal of Hepatology. 2021; 75(6): 1452
[Pubmed]  [Google Scholar] [DOI]
2 Auditory and visual P300 event-related potentials to detect minimal hepatic encephalopathy
Ángel Daniel Santana Vargas, Fátima Higuera-De la Tijera, JOSE LUIS PEREZ HERNANDEZ
Revista Española de Enfermedades Digestivas. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy
Xianghui Han, Zhanyang Luo, Wenyi Wang, Peiyong Zheng, Tian Li, Zubing Mei, Jianyi Wang
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
4 Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
Segundo Moran, Marlene López-Sánchez, María del Pilar Milke-García, Gustavo Rodríguez-Leal
World Journal of Gastroenterology. 2021; 27(22): 3050
[Pubmed]  [Google Scholar] [DOI]
5 Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy
C.E. Coronel-Castillo, J. Contreras-Carmona, A.C. Frati-Munari, M. Uribe, N. Méndez-Sánchez
Revista de Gastroenterología de México (English Edition). 2020; 85(1): 56
[Pubmed]  [Google Scholar] [DOI]
6 Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids
Michael J. Hamill, Raffi Afeyan, Manu V. Chakravarthy, Tony Tramontin
iScience. 2020; 23(10): 101628
[Pubmed]  [Google Scholar] [DOI]
7 L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Ee Teng Goh, Caroline S Stokes, Sandeep S Sidhu, Hendrik Vilstrup, Lise Lotte Gluud, Marsha Y Morgan
Cochrane Database of Systematic Reviews. 2018; 2019(6)
[Pubmed]  [Google Scholar] [DOI]
8 Screening for minimal hepatic encephalopathy among asymptomatic drivers with chronic liver disease
Mohammad Eltaher Abdelrahman, Saad Zaky Mahmoud, Anwar M. Ali, Haitham Ahmed Abdalla T. El-Khateeb, Ghada A. Mohamed
The Egyptian Journal of Internal Medicine. 2018; 30(4): 217
[Pubmed]  [Google Scholar] [DOI]


Read this article